Areteia Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024

Contributed by: Business Wire

Logo

Tags

Biotechnology

Pharmaceutical

Health

J.P. Morgan Healthcare Conference

More Like This

Areteia Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday January 14, 2025

Areteia Therapeutics Announces Additional $75MM in Series A Financing for Oral Dexpramipexole in Eosinophilic Asthma

(Photo: Business Wire)

Areteia Therapeutics Announces Appointment of Daniel Becker, M.D., Ph.D. To Board of Directors

Areteia Therapeutics Announces Appointments of Donald J. Hayden, Jr. and Ian F. Smith to Its Board of Directors

iTeos to Present at the 42nd Annual J.P. Morgan Healthcare Conference

iTeos to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Calliditas Therapeutics to Present Data at ERA 2024 May 23 - 26 in Stockholm

iTeos to Present Preclinical Data on Potential Best-In-Class Anti-TREM2 Antibody, EOS-215, and Novel PTPN1/2 Inhibitor at the American Association for Cancer Research Annual Meeting 2025